Immunology and Microbiology
Adenoviridae
29%
Adoptive Immunity
10%
Antigen Specificity
15%
Bagg Albino Mouse
9%
CD137 Ligand
15%
Cell Differentiation
11%
Cell Function
16%
Cell Infiltration
10%
Cell Line
9%
Cell Maturation
18%
Colon
34%
Cytokine
27%
Cytotoxic T-Cell
17%
Dendritic Cell
21%
Gene Targeting
14%
Granulocyte
9%
Granulocyte Macrophage Colony-Stimulating Factor
12%
Hepatitis B Virus
10%
Herpes Simplex Virus
19%
Immune Response
20%
Immune Tolerance
11%
Immunity
70%
Immunosuppression
9%
Immunosuppressive Drug
22%
Immunotherapy
33%
Interleukin 12
27%
Interleukin 2
21%
Intravenous Immunoglobulin
19%
Leukocyte Immunoglobulin-Like Receptors
9%
LILRB2
10%
Low Drug Dose
10%
Macrophage
30%
Mouse Model
16%
Myeloid
47%
Myeloid-Derived Suppressor Cell
100%
Natural Killer Cell
20%
Prostate
10%
Regulatory T Cell
30%
Sunitinib
11%
Syngenic
15%
T Cell
73%
T Cell Activation
11%
T-Helper Cell
12%
Th17 Cell
11%
Transplantation Tolerance
10%
Tumor Cell
9%
Tumor Gene
10%
Tumor Immunity
13%
Tumor Volume
9%
Tumor-Associated Macrophage
10%
Medicine and Dentistry
Adenoviridae
32%
Breast Cancer
11%
Cancer
9%
Cancer Cell
8%
Clinical Trial
13%
Combination Therapy
16%
Cytokine
7%
Cytotoxic T-Cell
16%
Diseases
8%
Ex Vivo
8%
Ganciclovir
24%
Gene Targeting
7%
Gene Therapy
39%
Genetic Transduction
10%
Granulocyte Macrophage Colony Stimulating Factor
10%
Herpes Simplex Virus
23%
Immune Checkpoint Inhibitor
8%
Immune Response
7%
Immunity
20%
Immunocompetent Cell
7%
Immunosuppressive Drug
8%
Immunotherapy
18%
in Vivo Gene Transfer
7%
Interleukin 12
11%
Interleukin 2
16%
Leukocyte
9%
Liver Metastasis
10%
Lung Cancer
16%
Lymphocyte
8%
Malignant Neoplasm
10%
Metastatic Carcinoma
13%
Myeloid Cell
22%
Myeloid-Derived Suppressor Cell
37%
Neoplasm
70%
Overall Survival
8%
Pancreas Adenocarcinoma
10%
Pancreatic Adenocarcinoma Cell Line
8%
Primary Tumor
16%
Programmed Cell Death
15%
Prostate Cancer
16%
Receptor
12%
Respiratory Syncytial Virus
11%
Stem Cell Factor
7%
Stereotactic Body Radiation Therapy
12%
T Cell
13%
Thymidine Kinase
35%
Triple Negative Breast Cancer
15%
Tumor Cell
10%
Tumor Immune Microenvironment
10%
Tumor Microenvironment
9%
Keyphrases
Adenoviral
13%
Adenovirus
32%
Apoptosis
8%
CD115
7%
Cell-based
7%
Colon Adenocarcinoma
11%
Combination Gene Therapy
11%
Combination Therapy
15%
Cytokine Gene Therapy
11%
Cytokine Genes
9%
FasL
7%
Ganciclovir
10%
Gene Delivery
11%
Gene Therapy
27%
Granulocyte Colony-stimulating Factor (G-CSF)
7%
Hepatic Metastasis
13%
Herpes Simplex Virus Thymidine Kinase
16%
HSV-TK
9%
Immune Regulation
7%
Immune Tolerance
9%
In Cancer
8%
In Situ
10%
Interleukin-12 (IL-12)
19%
Interleukin-2
21%
Leukocyte Immune-type Receptors
10%
LILRB2
10%
Liver
12%
Liver Metastasis
7%
Lung Cancer
11%
Macrophages
9%
Melanoma
10%
Metastasis
10%
Metastatic Colorectal Cancer (mCRC)
9%
Myeloid Cells
8%
Myeloid-derived Suppressor Cells
48%
Oligometastases
10%
Phase II Trial
7%
Prostate Cancer
8%
Regulatory T (Treg) Cells
10%
Stereotactic Body Radiation Therapy
8%
Suicide Gene
11%
Suicide Gene Therapy
11%
Sunitinib
11%
Thymidine Kinase Gene
12%
Transplantation
11%
Transplantation Tolerance
10%
Tumor
24%
Tumor Cells
11%
Tumor Immunity
16%
Tumor Microenvironment
11%
